Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
PDGFR inhibitor.
Impurity of rapamycin
Naturally occurring sesteterpenoid.
Natriuretic, vasodilatory peptide; B1/2 agonist...
Electrophile used in 2’-hydroxyl acylation of...
Tetrapeptide, binds cell surface integrins.
EGFR inhibitor.
Triterpene saponin found in species of Panax.
TRPA1 agonist, xanthine oxidase inhibitor.
Mycotoxin produced by Alternaria; topoisomerase...
Pyrimidine, glucose analog, used to induce diab...
PDGFR and c-Kit inhibitor.
Vinca alkaloid found in Catharanthus; microtubu...
SIRT inhibitor.
Endogenous antimicrobial peptide, binds bacteri...
Tetracycline; protein translation inhibitor, MM...
ACE inhibitor.
Endogenous peptide hormone, somatostatin analog...
Aminothiol, CoA component; ulcer inducer.
AChE inhibitor, D2 antagonist.